NumFin

Medcomtech, S.A.

Symbol: MED.MC

EURONEXT

0.69

EUR

Market price today

  • 0.0000

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 8.92M

    MRK Cap

  • 0.00%

    DIV Yield

Medcomtech, S.A. (MED-MC) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Medcomtech, S.A. (MED.MC). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Medcomtech, S.A., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009

balance-sheet.row.cash-and-short-term-investments

011.61.8
1.4
1.1
0.5
0.6
1.6
1.6
1.9
1
1
0.8
0.6

balance-sheet.row.short-term-investments

000.10.1
0.1
0
0.1
0.2
1
0.6
0.7
0.8
0.9
0.6
0.4

balance-sheet.row.net-receivables

0009.4
0
0
0
0
0
0
0
13.5
14.4
0
0

balance-sheet.row.inventory

07.46.36.1
6.1
5.9
13.5
14.8
13.3
10.6
9.4
7.9
7.6
6.7
3.3

balance-sheet.row.other-current-assets

0000
0
0
0
0
0
0
0
0.2
0
0
0

balance-sheet.row.total-current-assets

019.519.117.3
15.7
16.9
24.7
28.2
27.2
23.4
23.3
22.6
23
18.2
9.7

balance-sheet.row.property-plant-equipment-net

03.93.72.3
1.7
2.4
4.9
5.3
4
3.1
2.8
2.9
3.2
2.2
1.2

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

00.20.20.3
0.3
1.4
2.3
2.9
0.3
0.3
0.2
0.2
0.1
0.1
0.1

balance-sheet.row.goodwill-and-intangible-assets

00.20.20.3
0.3
1.4
2.3
2.9
0.3
0.3
0.2
0.2
0.1
0.1
0.1

balance-sheet.row.long-term-investments

03.544.5
4.8
0.2
0.1
0
0.2
0.4
0.1
-0.6
0.5
0.7
-0.4

balance-sheet.row.tax-assets

00.40.30
0
0.7
0.7
0.6
0.1
0.1
0
0.4
0.1
0.2
0

balance-sheet.row.other-non-current-assets

000.10.1
0.2
2.1
0.4
0.6
11.6
7.2
3.9
2
0.9
1.3
0.4

balance-sheet.row.total-non-current-assets

08.18.37.2
6.9
6.8
8.2
9.1
10.4
7.4
5.1
3.8
4.8
3.8
1.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

027.527.524.5
22.6
23.6
32.9
37.3
37.5
30.8
28.3
26.4
27.8
22
11

balance-sheet.row.account-payables

08.910.38
6.8
10.5
9.5
9.8
6.3
4
4.3
2.8
1.8
2.3
1.3

balance-sheet.row.short-term-debt

01.11.31.1
0.4
0.3
4.2
6.9
8.1
5.7
4.5
4.3
8.1
5.1
2.7

balance-sheet.row.tax-payables

0000
0
0
0
0
0.1
0.1
0.1
0
0
0
0.3

balance-sheet.row.long-term-debt-total

044.63.1
2.1
2.9
1.3
2.6
2
1.4
1.1
3.2
2.1
0.8
0.7

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

03.63.82.3
3.3
4.5
5.2
4.4
3.8
2.5
1.9
1
3.6
0.5
1.5

balance-sheet.row.total-non-current-liabilities

0139.39.2
6.2
7.5
7.4
10.1
3.5
3.2
2.2
3.6
2.2
2.1
2.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01.21.60
0
0
0.1
0.2
0.1
0.2
0.3
0.6
0.7
0.4
0.2

balance-sheet.row.total-liab

026.624.820.5
16.7
22.8
26.3
31.1
21.7
15.4
12.8
11.7
15.8
10.1
7.9

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.10.10.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1

balance-sheet.row.retained-earnings

0-1.6-1.3-1.8
4.2
-8.5
-2.4
-2.9
0.4
0.1
0.3
0.4
0.2
1.5
1.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

0000
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

02.53.95.7
1.6
12.2
11.8
10.9
15.3
15.3
15.1
14.3
11.8
10.3
1.8

balance-sheet.row.total-stockholders-equity

012.74
5.9
3.8
9.5
8.2
15.8
15.4
15.5
14.7
12
11.9
3.1

balance-sheet.row.total-liabilities-and-stockholders-equity

027.527.524.5
22.6
23.6
32.9
37.3
37.5
30.8
28.3
26.4
27.8
22
11

balance-sheet.row.minority-interest

0000
0
-3
-2.9
-2.1
0
0
0
0
0
0
0

balance-sheet.row.total-equity

012.74
5.9
0.8
6.6
6.1
15.8
15.4
15.5
14.7
12
11.9
3.1

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-

Total Investments

03.64.14.6
4.8
0.2
0.2
0.2
1.2
1
0.8
0.1
1.4
1.4
0

balance-sheet.row.total-debt

05.15.94.2
2.6
3.2
5.5
9.5
10.1
7
5.6
7.5
10.2
6
3.4

balance-sheet.row.net-debt

04.14.42.5
1.3
2.1
5.1
9.1
9.5
6
4.3
7.3
10.1
5.8
3.3

Cash Flow Statement

The financial landscape of Medcomtech, S.A. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009

cash-flows.row.net-income

0-1.7-1.5-1.8
4.5
-9.6
-3.3
0
0.5
0.8
1.1
0.5
0.3
1.8
1.8

cash-flows.row.depreciation-and-amortization

010.90.8
1
2
2.2
1.2
1.1
1
0.7
0.6
0.6
0.4
0.3

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2.50.1-1.1
-3.4
4.7
2.9
1
-1.6
-1.1
0.6
1
-4.5
-7.2
-3.6

cash-flows.row.account-receivables

0000
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-1.5-0.5-0.6
-0.7
0.1
1
-0.3
-2.8
-1.3
-1.8
-0.3
-1
-3.4
0

cash-flows.row.account-payables

0000
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-10.7-0.6
-2.7
4.5
1.9
1.3
1.2
0.2
2.4
1.3
-3.4
-3.8
-3.6

cash-flows.row.other-non-cash-items

01.10.91.2
-4.5
6
-0.2
0.1
-0.3
0.3
0.5
0.4
0
-0.7
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1.2-2.4-1.5
-0.6
-0.8
-1.1
-1.6
-2.1
-1.5
-0.7
-0.6
-1.3
-1.2
-0.3

cash-flows.row.acquisitions-net

0000.1
4.6
0.5
0
-1.1
-2.3
-1.4
-0.7
-0.4
-0.2
0
0

cash-flows.row.purchases-of-investments

00-0.1-0.5
-0.2
0
0
0
0
0
-0.1
-0.8
-0.1
-1.9
-0.1

cash-flows.row.sales-maturities-of-investments

0000.1
0
0.2
0.1
0.1
0
0
0.1
2.4
0
0.3
0

cash-flows.row.other-investing-activites

000.2-0.1
0.1
-0.4
-0.2
0
-0.1
-0.1
-0.1
-0.1
-0.1
0
-0.1

cash-flows.row.net-cash-used-for-investing-activites

0-1.2-2.3-1.9
3.9
-0.7
-1
-2.6
-4.4
-2.8
-1.3
0.6
-1.6
-2.7
-0.4

cash-flows.row.debt-repayment

0-1.3-0.10
-1.9
-2.3
-6.2
-5.9
-0.6
-2
-1.9
-5.9
-2.6
-2.8
-1.4

cash-flows.row.common-stock-issued

0000
0.7
0
0
0
0
0
0.5
1.4
0
0
0

cash-flows.row.common-stock-repurchased

0000
-0.1
0
0
-0.1
-0.1
-0.1
0
-0.1
0
-0.5
0

cash-flows.row.dividends-paid

0000
0
0
0
-0.3
0
-0.5
0
-0.7
0
0
0

cash-flows.row.other-financing-activites

041.93.3
0
0.6
5.6
6.2
4.8
4.7
0.9
1.5
7.8
11.7
3

cash-flows.row.net-cash-used-provided-by-financing-activities

02.71.73.2
-1.2
-1.7
-0.6
-0.1
4.2
2.1
-0.5
-3
5.2
8.3
1.6

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
-0.1
0
0
0
-0.3
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-0.5-0.30.4
0.3
0.6
0.1
-0.4
-0.5
-0.2
1
0.1
0
-0.1
-0.3

cash-flows.row.cash-at-end-of-period

011.51.7
1.3
1.1
0.5
0.3
0.6
1.1
1.3
0.2
0.1
0.1
0.2

cash-flows.row.cash-at-beginning-of-period

01.51.71.3
1.1
0.5
0.4
0.6
1.1
1.3
0.2
0.1
0.1
0.2
0.5

cash-flows.row.operating-cash-flow

0-20.4-0.9
-2.4
3.1
1.6
2.4
-0.2
0.9
2.8
2.6
-3.6
-5.7
-1.5

cash-flows.row.capital-expenditure

0-1.2-2.4-1.5
-0.6
-0.8
-1.1
-1.6
-2.1
-1.5
-0.7
-0.6
-1.3
-1.2
-0.3

cash-flows.row.free-cash-flow

0-3.2-2.1-2.4
-3
2.3
0.5
0.7
-2.4
-0.5
2.2
1.9
-4.9
-6.8
-1.9

Income Statement Row

Medcomtech, S.A.'s revenue saw a change of NaN% compared with the previous period. The gross profit of MED.MC is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009

income-statement-row.row.total-revenue

022.420.218.6
22.3
24.3
28.6
27.3
23
20.2
18.4
16.7
14.5
12.3
10.1

income-statement-row.row.cost-of-revenue

07.58.27.4
6.6
10.9
11.9
10.6
9.4
8
7.3
6.1
4.5
4.7
3.5

income-statement-row.row.gross-profit

014.91211.1
15.6
13.4
16.7
16.6
13.6
12.2
11.1
10.6
10
7.6
6.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-0.2-0.30
-0.4
-2.1
-0.1
-0.1
0
0
0
0
0
-0.1
0

income-statement-row.row.operating-expenses

014.111.411.3
14.8
16.1
18.8
18.2
12
10.1
9.2
8.9
9.1
5.4
4.3

income-statement-row.row.cost-and-expenses

021.619.618.7
21.4
26.9
30.7
28.8
21.4
18.1
16.5
15
13.6
10
7.8

income-statement-row.row.interest-income

00.50.40
0
0
0
0
0
0.1
0
0
0
0
0

income-statement-row.row.interest-expense

0111
0.9
1.4
1.2
1.4
1
0.8
0.7
0.9
0.7
0.4
0.4

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1.2-1.1-1.6
-4.3
-2
-1.6
-1.5
-0.8
-1.1
-0.6
-1.1
-90.4
-0.4
-0.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-0.2-0.30
-0.4
-2.1
-0.1
-0.1
0
0
0
0
0
-0.1
0

income-statement-row.row.total-operating-expenses

0-1.2-1.1-1.6
-4.3
-2
-1.6
-1.5
-0.8
-1.1
-0.6
-1.1
-90.4
-0.4
-0.5

income-statement-row.row.interest-expense

0111
0.9
1.4
1.2
1.4
1
0.8
0.7
0.9
0.7
0.4
0.4

income-statement-row.row.depreciation-and-amortization

010.90.8
1
2
2.2
1.2
1.1
1
0.7
0.6
0.6
0.4
0.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

00.30.2-0.2
8.8
-7.5
-1.7
-1.8
1.6
1.9
1.7
1.7
90.6
2.2
2.3

income-statement-row.row.income-before-tax

0-0.9-0.9-1.8
4.5
-9.6
-3.3
-3.2
0.8
0.8
1.1
0.5
0.3
1.8
1.8

income-statement-row.row.income-tax-expense

0-0.1-0.20
0.4
-0.5
0
0.3
0.2
0.2
0.3
0.2
0.1
0.3
0.5

income-statement-row.row.net-income

0-0.8-0.7-1.8
4.2
-8.5
-2.4
-2.9
0.4
0.6
0.8
0.4
0.2
1.5
1.3
Similar Stocks
You may also be interested in:
MEPDF
MediPal Holdings Corporation.
16.43 USD
PNK
CHME
China Medicine Corporation.
0.028 USD
PNK
EXHI
Exlites Holdings International, Inc..
0.07 USD
PNK
601607.SS
Shanghai Pharmaceuticals Holding Co., Ltd.
18.21 CNY
SHH
0673.HK
China Health Group Limited.
1.08 HKD
HKSE
MLTO
MEDirect Latino, Inc..
0.000001 USD
PNK
ABC
AmerisourceBergen Corporation.
179.98 USD
NYSE
3183.T
WIN-Partners Co., Ltd..
1242 JPY
JPX
GEG
Great Elm Group, Inc..
1.97 USD
NASDAQ

Frequently Asked Question

What is Medcomtech, S.A. (MED.MC) total assets?

Medcomtech, S.A. (MED.MC) total assets is 27533160.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.666.

What is company free cash flow?

The free cash flow is 0.000.

What is enterprise net profit margin?

The net profit margin is -0.035.

What is firm total revenue?

The total revenue is 0.012.

What is Medcomtech, S.A. (MED.MC) net profit (net income)?

The net profit (net income) is -778537.000.

What is firm total debt?

The total debt is 5101358.000.

What is operating expences number?

The operating expences are 14101826.000.

What is company cash figure?

Enretprise cash is 0.000.